Genetic investigations of CFTR mutations in congenital absence of vas deferens, uterus, and vagina as a cause of infertility

Journal of Andrology

Volumn 29, Issue 5, 2008, Pages 506-513

  Radpour, Ramin ^a,b   Gourabi, Hamid ^b   Dizaj, Ahmad Vosough ^b   Holzgreve, Wolfgang ^a   Zhong, Xiao Yan ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CHLORIDE CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR;

AZOOSPERMIA; CHROMOSOME DELETION; CYSTIC FIBROSIS; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENE SEGREGATION; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INCIDENCE; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MALE GENITAL TRACT MALFORMATION; MISSENSE MUTATION; NONSENSE MUTATION; OLIGOSPERMIA; PENETRANCE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; UTERUS MALFORMATION; VAGINA APLASIA; VAS DEFERENS;

ALLELES; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENOTYPE; HUMANS; INFERTILITY; MALE; MUTATION; PHENOTYPE; POLYMORPHISM, GENETIC; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS; UTERUS; VAGINA; VAS DEFERENS;

EID: 52949149656     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.2164/jandrol.108.005074     Document Type: Review

References (42)

1. Augarten A, Yahav Y, Kerem BS, Halle D, Laufer J, Szeinberg A, Dor J, Mashiach S, Gazit E, Madgar I. Congenital bilateral absence of vas deferens in the absence of cystic fibrosis. Lancet. 1994;344: 1473-1474.
2. Blau H, Freud E, Mussaffi H. Urogenital abnormalities in male children with cystic fibrosis. Arch Dis Child. 2002;87:135-138.
3. Cascio M. Structure and function of the glycine receptor and related nicotinicoid receptors. J Biol Chem. 2004;279:19383-19386.
4. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M, Nunes V, Férec C, Estivill X. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. New Engl J Med. 1995; 332:1475-1480.
5. Chu CS, Trapnell BC, Curristin S, Cutting GR, Crystal RG. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA. Nat Genet. 1993;3:151-156.
6. Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, et al. Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mut. 2000; 16:143-156.
7. Cuppens H, Lin W, Jaspers M, Costes B, Teng H, Vankeerberghen A, Jorissen M, Droogmans G, Reynaert I, Goossens M, Nilius B, Cassiman JJ. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes-the polymorphic (TG)m locus explains the partial penetrance of the ST polymorphism as a disease mutation. J Clin Invest. 1998;101:487-496.
8. Cystic Fibrosis Genetic Analysis Consortium. Cystic fibrosis mutation database. http://www.genet.sickkids.on.ca. Updated March 2, 2007. Accessed June 30, 2008.
9. Daudin M, Bieth E, Bujan L, Massat G, Pontonnier F, Mieusset R. Congenital bilateral absence of the vas deferens: clinical characteristics, biological parameters, cystic fibrosis transmembrane conductance regulator gene mutations, and implications for genetic counseling. Fertil Steril. 2000;74:1164-1174.
10. Delaney SJ, Rich DP, Thomson SA, Hargrave MR, Lovelock PK, Welsh MJ, Wainwright BJ. Cystic fibrosis transmembrane conductance regulator splice variants are not conserved and fail to produce chloride channels. Nat Genet. 1993;4:426-431.
11. Denning CR, Sommers SC, Quigley HJ. Infertility in male patients with cystic fibrosis. Pediatrics. 1968;41:7-17.
12. Dohle GR, Halley DJJ, Van Hemel JO, van den Ouwel AMW, Pieters MHEC, Weber RFA, Govaerts LCP. Genetic risk factors in infertile men with severe oligozoospermia and azoospermia. Hum Reprod. 2002;17:13-16.
13. Dork T, Dworniczak B, Aulehla-Scholz C, Wieczorek D, Bohm I, Mayerova A, Seydewitz HH, Nieschlag E, Meschede D, Horst J, Pander HJ, Sperling H, Ratjen F, Passarge E, Schmidtke J, Stuhrmann M. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet. 1997;100:365-377.
14. Dutzler R, Campbell EB, Cadene M, Chait BT, MacKinnon R. X-ray structure of a ClC chloride channel at 3.0 A reveals the molecular basis of anion selectivity. Nature. 2002;415:287-294.
15. - channels by protein kinase A corrected by insertion of CFTR. Nature. 1992; 358:581-584.
16. Jarvi K, Zielenski J, Wilschanski M, Durie P, Buckspan M, Tullis E, Markiewicz D, Tsui LC. Cystic fibrosis transmembrane conductance regulator and obstructive azoospermia. Lancet. 1995;345: 1578.
17. Johannesson M, Bogdanovic N, Nordqvist AC, Hjelte L, Schalling M. Cystic Fibrosis mRNA expression in rat brain: cerebral cortex and preoptic area. Neuroreport. 1997;8:535-539.
18. Johannesson M, Landgren BM, Csemiczky G, Hjelte L, Gottlieb C. Female patients with cystic fibrosis suffer from reproductive endocrinological disorders despite good clinical status. Hum Reprod. 1998;13:2092-2097.
19. Josserand RN, Bey-Omar F, Rollet J, Lejeune H, Boggio D, Durand DV, Durieu I. Cystic fibrosis phenotype evaluation and paternity outcome in 50 males with congenital bilateral absence of vas deferens. Hum Reprod. 2001;16:2093-2097.
20. Kristidis P, Boson D, Corey M, Markiewicz D, Rommens J, Tsui LC, Durie P. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet. 1992;50:1178-1184.
21. Locher KP, Lee AT, Rees DC. The E. coli BtuCD structure. A framework for ABC transporter architecture and mechanism. Science. 2002;296:1091-1098.
22. Mak V, Zielenski J, Tsui LC, Durie P, Zini A, Martin S, Langley TB, Jarvi KA. Cystic fibrosis gene mutations and infertile men with primary testicular failure. Hum Reprod. 2000;15:436-439.
23. Mercier B, Verlingue C, Lissens W, Silber SJ, Novelli G, Bonduelle M, Audrézet MP, Férec C. Is congenital bilateral absence of vas deferens a primary form of cystic fibrosis? Analyses of the CFTR gene in 67 patients. Am J Hum Genet. 1995;56:272-277.
24. Radpour R, Gilani MA, Gourabi H, Dizaj AV, Mollamohamadi S. Molecular analysis of the IVS8-T splice variant ST and M470V exon 10 missense polymorphism in Iranian males with congenital bilateral absence of the vas deferens. Mol Hum Reprod. 2006a;12: 469-473.
25. Radpour R, Gourabi H, Gilani MA, Dizaj AV. Correlation between CFTR gene mutations in Iranian men with congenital absence of the vas deferens and anatomical genital phenotype. J Androl. 2008;29:35-40.
26. Radpour R, Gourabi H, Gilani MA, Dizaj AV, Rezaee M, Mollamohamadi S. Two novel missense and one novel nonsense CFTR mutations in Iranian males with congenital bilateral absence of the vas deferens. Mol Hum Reprod. 2006b;12:717-721.
27. Radpour R, Gourabi H, Sadighi Gilani MA, Vosough Dizaj A. Molecular study of (TG)m(T)n polymorphism in Iranian males with congenital bilateral absence of the vas deferens. J Androl. 2007;28:541-547.
28. Rave-Harel N, Madgar I, Goshen R, Nissim-Rafinia M, Ziadni A, Rahat A, Chiba O, Kalman YM, Brautbar C, Levinson D, et al. CFTR haplotype analysis reveals genetic heterogeneity in the etiology of congenital bilateral aplasia of the vas deferens. Am J Hum Genet. 1995;56:1359-1366.
29. Rosenberg MF, Callaghan R, Modok S, Higgins CF, Ford RC. Three-dimensional structure of P-glycoprotein. The transmembrane regions adopt an asymmetric configuration in the nucleotide-bound state. J Biol Chem. 2004;280:2857-2862.
30. Rosenberg MF, Kamis AB, Aleksandrov LA, Ford RC, Riordan JR. Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem. 2005;279: 39051-39057.
31. Sokol RZ. Infertility in men with cystic fibrosis. Curr Opin Pulm Med. 2001;7:421-426.
32. Strong TV, Wilkinson DJ, Mansoura MK, Devor DC, Henze K, Yang Y, Wilson JM, Cohn JA, Dawson DC, Frizzell RA, Collins FS. Fxpression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance. Hum Mol Genet. 1993; 2:225-230.
33. Timmreck LS, Gray MR, Handelin B, Allito B, Rohlfs E, Davis AJ, Gidwani G, Reindollar RH. Analysis of cystic fibrosis transmembrane conductance regulator gene mutations in patients with congenital absence of the uterus and vagina. Am J Med Genet. 2003;120:72-76.
34. Tizzano EF, Chitayat D, Buchwald M. Cell-specific localization of CFTR mRNA shows developmentally regulated expression m human fetal tissues. Hum Mol Genet. 1993;2:219-224.
35. Trezise A, Linder C, Grieger D, Thompson E, Meunier H, Griswold M, Buchwald M. CFTR expression is regulated during both the cycle of the seminiferous epithelium and the oestrous cycle of rodents. Nat Genet. 1993;3:157-164.
36. Tuerlings JHAM, Mol B, Kremer JAM, Looman M, Meuleman EJH, Te Meerman GJ, Buys CHCM, Merkus HMWM, Scheffer H. Mutation frequency of cystic fibrosis transmembrane regulator is not increased in oligozoospermic male candidates for intracyto-plasmic sperm injection. Fertil Steril. 1998;69:899-903.
37. Unwin N. Structure and action of the nicotinic acetylcholine receptor explored by electron microscopy. FEBS Letts. 2003;555: 91-95.
38. Van der Ven K, Messer L, Van der Ven H, Jeyendran RS, Ober C. Cystic fibrosis mutation screening in healthy men with reduced sperm quality. Hum Reprod. 1996;11:513-517.
39. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993;73:1251-1254.
40. Welsh MJ, Smith AE. Cystic fibrosis. Scientific American. 1995;273: 52-59.
41. Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations. J Pediatr. 1995;127:705-710.
42. Xu WM, Shi QX, Chen WY, Zhou CX, Ni Y, Rowlands DK, Yi Liu G, Zhu H, Ma ZG, Wang XF, Chen ZH, Zhou SC, Dong HS, Zhang XH, Chung YW, Yuan YY, Yang WX, Chan HC. Cystic fibrosis transmembrane conductance regulator is vital to sperm fertilizing capacity and male fertility. Proc Natl Acad Sci U S A. 2007;104:9816-9821.